NCT05365802View on ClinicalTrials.gov

FAPI PET for Lung Fibrosis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 16, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Interstitial Lung DiseaseIdiopathic Interstitial PneumoniasDrug-Induced PneumonitisHypersensitivity PneumonitisRadiation PneumonitisPneumoconiosisPulmonary Fibrosis
Interventions
DRUG

68Ga-FAPi-46

Radiopharmaceutical will be administered via IV

PROCEDURE

Computed Tomography

As part of PET/CT scan

PROCEDURE

Positron Emission Tomography

As part of PET/CT scan

PROCEDURE

High Resolution Computed Tomography

Will be conducted immediately after FAPI PET/CT

Trial Locations (1)

90095

RECRUITING

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER